Recordati Expands Treasury Stock with Latest Share Buyback Tranche

The latest update is out from Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ).

Recordati has provided an update on its ongoing share buyback program, initiated in December 2025 under a shareholder resolution to accumulate shares for existing and future equity-based incentive plans for Group management. Between 23 and 27 February 2026, the company repurchased 53,599 ordinary shares on the EXM market at a weighted average price of €48.0268, bringing its total treasury holding to 5,293,843 shares, or 2.531% of its share capital.

The latest tranche of buybacks underscores Recordati’s continued use of treasury stock to support stock option and performance share schemes that align management incentives with shareholder interests. By steadily increasing its treasury share position, the group adds flexibility in structuring current and future incentive plans without immediately diluting existing investors, which can be relevant for long-term capital management and governance objectives.

The most recent analyst rating on (IT:REC) stock is a Buy with a EUR57.50 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.

More about Recordati Industria Chimica e Farmaceutica SPA

Recordati Industria Chimica e Farmaceutica is an international pharmaceutical group listed on Borsa Italiana, operating across general and specialty medicine as well as rare diseases. The company runs an integrated model from clinical development through production, marketing and licensing of APIs and finished products, serving about 150 countries in EMEA, the Americas and APAC with over 4,580 employees.

Average Trading Volume: 331,180

Technical Sentiment Signal: Hold

Current Market Cap: €9.77B

Learn more about REC stock on TipRanks’ Stock Analysis page.